Microcrystalline tyrosine(MCT ®): A depot adjuvant in licensed allergy immunotherapy offers new opportunities in Malaria.
G. Cabral-Miranda, et al. Vaccines 2017, 5(4), 32.
Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax
G. Cabral-Miranda, et al. Vaccines 2017, 5(2), 10
Comparison of a novel microcrystalline tyrosine adjuvant with aluminium hydroxide for enhancing vaccination against seasonal influenza
M.D. Heath, et al. BMC Infectious Diseases (2017) 17:232
Clinical use of adjuvants in allergen immunotherapy
L. Klimek, et al. Expert Review of Clinical Immunology, 2017, 13:6, 599-610
Analysis of aluminium in rat following administration of allergen immunotherapy using either aluminium or microcrystalline-tyrosine-based adjuvants
S. A. McDougall, et al. Bioanalysis (2016) 8(6), 547–556
The adsorption of allergoids and 3-0-desacyl-4'-monophosphoryl lipid A (MPL®) to microcrystalline tyrosine (MCT) in formulations for use in allergy immunotherapy.
A.J. Bell, et al. Journal of Inorganic Biochemistry 152 (2015) 147–153
DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines
G.Cabral-Miranda, et al. MDPI (2018) 6(4):107
Vaccination with nanoparticles combined with micro adjuvants protects against cancer
M. Mohsen, et al. Journal for Immunotherapy of Cancer (2019) 7:114
Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT®)
M.D. Heath, et al. Frontiers Immunology (2020) 11:594911
Feel free to contact us if you have any questions
Please fill in all the fields
Click here for more information